Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease

Elyse N. Van Spyk, Kevin C. Chun, Kiana M. Samadzadeh, John H. Peters, Eugene S Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Circulating progenitor cells are integral to vascular health and effectively predict vascular reactivity. CD34 is a known marker of circulating progenitor cells. Few studies have examined the role of CD34+ cells in abdominal aortic aneurysm(AAA) disease and peripheral vascular disease (PVD). The aim of this study was to compare the percentage of CD34+ cells between patients with AAA versus PVD. Materials and methods: We collected peripheral whole blood from AAA or PVD patients. The blood was stained with fluorescently labeled antibodies against CD34 or isotype controls. We collected data using a flow cytometer and analyzed them. We also recorded risk factors such as hypertension, diabetes, total cholesterol, serum white blood cells, serum creatinine, body mass index, blood pressure, statin use, current smoking status, coronary artery disease, cerebral vascular accident, and chronic obstructive pulmonary disease. Results: We enrolled 24 patients in this study (AAA, n = 12; PVD, n = 12). The AAA patients had a greater percentage of CD34+ cells compared with PVD patients. (r = 0.84; P = 0.016). There were no significant risk factors differences between AAA and PVD patients. Conclusions: Based on CD34+ cell counts, AAA is a less severe vascular disease than PVD. Whether CD34+ cells can serve as a biomarker for risk stratification or a potential therapy warrants further study.

Original languageEnglish (US)
Pages (from-to)638-643
Number of pages6
JournalJournal of Surgical Research
Volume184
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Peripheral Vascular Diseases
Abdominal Aortic Aneurysm
Blood Vessels
Stem Cells
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Aortic Diseases
Serum
Vascular Diseases
Chronic Obstructive Pulmonary Disease
Accidents
Coronary Artery Disease
Creatinine
Body Mass Index
Leukocytes
Cell Count
Biomarkers
Smoking
Cholesterol
Blood Pressure
Hypertension

Keywords

  • Abdominal aortic aneurysm
  • CD34
  • Circulating progenitor cells
  • Endothelial progenitor cells
  • Flow cytometry
  • Peripheral vascular disease

ASJC Scopus subject areas

  • Surgery

Cite this

Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease. / Van Spyk, Elyse N.; Chun, Kevin C.; Samadzadeh, Kiana M.; Peters, John H.; Lee, Eugene S.

In: Journal of Surgical Research, Vol. 184, No. 1, 2013, p. 638-643.

Research output: Contribution to journalArticle

@article{b3147bc4da7b42f1a8e0e739da9b17a8,
title = "Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease",
abstract = "Background: Circulating progenitor cells are integral to vascular health and effectively predict vascular reactivity. CD34 is a known marker of circulating progenitor cells. Few studies have examined the role of CD34+ cells in abdominal aortic aneurysm(AAA) disease and peripheral vascular disease (PVD). The aim of this study was to compare the percentage of CD34+ cells between patients with AAA versus PVD. Materials and methods: We collected peripheral whole blood from AAA or PVD patients. The blood was stained with fluorescently labeled antibodies against CD34 or isotype controls. We collected data using a flow cytometer and analyzed them. We also recorded risk factors such as hypertension, diabetes, total cholesterol, serum white blood cells, serum creatinine, body mass index, blood pressure, statin use, current smoking status, coronary artery disease, cerebral vascular accident, and chronic obstructive pulmonary disease. Results: We enrolled 24 patients in this study (AAA, n = 12; PVD, n = 12). The AAA patients had a greater percentage of CD34+ cells compared with PVD patients. (r = 0.84; P = 0.016). There were no significant risk factors differences between AAA and PVD patients. Conclusions: Based on CD34+ cell counts, AAA is a less severe vascular disease than PVD. Whether CD34+ cells can serve as a biomarker for risk stratification or a potential therapy warrants further study.",
keywords = "Abdominal aortic aneurysm, CD34, Circulating progenitor cells, Endothelial progenitor cells, Flow cytometry, Peripheral vascular disease",
author = "{Van Spyk}, {Elyse N.} and Chun, {Kevin C.} and Samadzadeh, {Kiana M.} and Peters, {John H.} and Lee, {Eugene S}",
year = "2013",
doi = "10.1016/j.jss.2013.03.070",
language = "English (US)",
volume = "184",
pages = "638--643",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease

AU - Van Spyk, Elyse N.

AU - Chun, Kevin C.

AU - Samadzadeh, Kiana M.

AU - Peters, John H.

AU - Lee, Eugene S

PY - 2013

Y1 - 2013

N2 - Background: Circulating progenitor cells are integral to vascular health and effectively predict vascular reactivity. CD34 is a known marker of circulating progenitor cells. Few studies have examined the role of CD34+ cells in abdominal aortic aneurysm(AAA) disease and peripheral vascular disease (PVD). The aim of this study was to compare the percentage of CD34+ cells between patients with AAA versus PVD. Materials and methods: We collected peripheral whole blood from AAA or PVD patients. The blood was stained with fluorescently labeled antibodies against CD34 or isotype controls. We collected data using a flow cytometer and analyzed them. We also recorded risk factors such as hypertension, diabetes, total cholesterol, serum white blood cells, serum creatinine, body mass index, blood pressure, statin use, current smoking status, coronary artery disease, cerebral vascular accident, and chronic obstructive pulmonary disease. Results: We enrolled 24 patients in this study (AAA, n = 12; PVD, n = 12). The AAA patients had a greater percentage of CD34+ cells compared with PVD patients. (r = 0.84; P = 0.016). There were no significant risk factors differences between AAA and PVD patients. Conclusions: Based on CD34+ cell counts, AAA is a less severe vascular disease than PVD. Whether CD34+ cells can serve as a biomarker for risk stratification or a potential therapy warrants further study.

AB - Background: Circulating progenitor cells are integral to vascular health and effectively predict vascular reactivity. CD34 is a known marker of circulating progenitor cells. Few studies have examined the role of CD34+ cells in abdominal aortic aneurysm(AAA) disease and peripheral vascular disease (PVD). The aim of this study was to compare the percentage of CD34+ cells between patients with AAA versus PVD. Materials and methods: We collected peripheral whole blood from AAA or PVD patients. The blood was stained with fluorescently labeled antibodies against CD34 or isotype controls. We collected data using a flow cytometer and analyzed them. We also recorded risk factors such as hypertension, diabetes, total cholesterol, serum white blood cells, serum creatinine, body mass index, blood pressure, statin use, current smoking status, coronary artery disease, cerebral vascular accident, and chronic obstructive pulmonary disease. Results: We enrolled 24 patients in this study (AAA, n = 12; PVD, n = 12). The AAA patients had a greater percentage of CD34+ cells compared with PVD patients. (r = 0.84; P = 0.016). There were no significant risk factors differences between AAA and PVD patients. Conclusions: Based on CD34+ cell counts, AAA is a less severe vascular disease than PVD. Whether CD34+ cells can serve as a biomarker for risk stratification or a potential therapy warrants further study.

KW - Abdominal aortic aneurysm

KW - CD34

KW - Circulating progenitor cells

KW - Endothelial progenitor cells

KW - Flow cytometry

KW - Peripheral vascular disease

UR - http://www.scopus.com/inward/record.url?scp=84884674426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884674426&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2013.03.070

DO - 10.1016/j.jss.2013.03.070

M3 - Article

C2 - 23680469

AN - SCOPUS:84884674426

VL - 184

SP - 638

EP - 643

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -